Patent classifications
A61Q19/007
Personal care products
The invention relates to a personal care product for alleviating skin dryness, includes facial skin dryness, breast skin dryness and vulval dryness and for restoring vaginal flora, acidic pH in the vagina, and vaginal health. Embodiments of the personal care product include a formulation including at least about 83 wt. % plant-based glycerides; from about 0.05 wt. % to about 0.15 wt. % sodium hyaluronate; and from about 0.01 wt. % to about 1.5 wt. % sea buckthorn powder. Another embodiment includes a personal care product including at least 55 wt. % plant-based glycerides and from about 20 wt. % to about 42 wt. % sucrose. The personal care product may also include shea olein. The person care product is substantially free of added water, alcohol, synthetic chemical, anti-microbial agent, and synthetic hormone.
Topical skin compositions for treating rosacea and skin redness
A method of reducing the appearance of skin redness is disclosed. The method can include topically applying to reddened skin an effective amount of a composition that includes a water soluble Phoenix dactylifera seed extract, an essential oil from the leaves of tea tree, an aqueous Myrothamnus flabellifolia leaf and stem extract, and a saccharide isomerate comprising an exopolysaccharide of Vibrio alginolyticus, wherein the appearance of skin redness is reduced.
COMPOSITION AND APPLICATION THEREOF IN PREPARATION OF SKIN CARE PRODUCTS FOR REGULATING SKIN BIORHYTHM
A skin care composition for regulating skin biorhythm, comprising: a skin conditioning agent A, a skin conditioning agent B, and adenosine. The skin conditioning agent A comprises glycoprotein, amino acid, a preservative, a stabilizing agent, and water, and the skin conditioning agent B comprises glutamine-based ethyl imidazole, a preservative, and water. The skin care composition can replenish moisture and promote cellular energy synthesis, and can solve the skin problem of people who stay up late.
ANTIMICROBIAL SKIN CREAM
This invention relates to compounds that treat microbial skin infections. Previously, powered forms of talk were difficult to apply to skin without becoming a lung irritant. Embodiments of the present invention use talc, lanolin, petroleum jelly, sodium lauryl ether sulfate, sodium chloride, water, sodium salicylate, Lauryl ether sulfate, Isopropyl palmitate, propylene glycol, mineral oil, and sodium benzoate.
Method of improving penetration of a vitamin B3 compound into skin
Disclosed is a method of improving the penetration of a vitamin B.sub.3 compound into skin. The method involves a skin care regimen in which at least two skin care compositions are used in sequence to treat a target portion of skin where a skin health or appearance benefit is desired. The first composition applied to the skin is a low-pH skin care composition that contains a first concentration of a vitamin B.sub.3 compound. The second skin care composition applied to the skin is a conventional skin care composition that contains a higher concentration of the vitamin B.sub.3 compound than the first composition. When applied in the proper sequence, the regimen results in an unexpectedly high vitamin B.sub.3 flux into the skin.
Topical skin compositions for treating wrinkles
Disclosed is a method of treating a fine line or wrinkle in a person's skin, the method comprising topically applying to the fine line or wrinkle a composition comprising an effective amount of Commiphora mukul resin or an extract thereof that includes oleo gum resin, glycerin, water, and hyaluronic acid or a salt form thereof, wherein topical application of the composition to the fine line or wrinkle reduces the appearance of the fine line or wrinkle.
Composition for preventing or treating scars
The present invention relates to a composition for preventing or treating scars and a preparation method therefor. The composition, according to one aspect, comprises a pigment and silicone oil, and may be stably formulated into a formulation adequate for spreading on the skin, and may inhibit the formation of scars or reduce already existing scars by forming a membrane on the skin, and has an effect whereby scars may be concealed by the pigment stably dispersed in the composition.
Array of wet wipe packages
Described herein is an array of wet wipe packages displayed via a merchandise display system. The array of wet wipe packages includes a first package, a second package, and a third package. The first package includes a first wet wipe having a first coform nonwoven material and a first lotion. The second package includes a second wet wipe having a second coform nonwoven material and a second lotion. The third package includes a third wet wipe having a third coform nonwoven material and a third lotion. The third lotion is different than the first lotion and the second lotion. The first coform nonwoven material, the second coform nonwoven material, and/or the third coform nonwoven material has from about 14.5% to about 45% cotton.
COMPOSITIONS COMPRISING 5-CHOLESTEN-3, 25-DIOL, 3-SULFATE (25HC3S) OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AND AT LEAST ONE CYCLIC OLIGOSACCHARIDE
Compositions comprising 5-cholesten-3, 25-diol, 3-sulfate (25HC3S) or pharmaceutically acceptable salt thereof and at least one cyclic oligosaccharide, e.g., a cyclodextrin (CD), are provided. The compositions may be used to prevent and/or treat a variety of diseases and conditions, including organ failure (e.g. acute liver failure), high cholesterol/high lipids, and various inflammatory diseases and conditions.
Agent for forming film on skin
The present disclosure relates to a skin film forming agent, and provides a skin film forming agent which comprises dimethiconol, hydride dimethicone and a cross-linking component, and thereby provides a skin film forming agent which has no problem of safety, and forms a film with high intensity, and thereby can solve peeling and slipping of the film and effectively improve skin disadvantages, particularly, wrinkles and elasticity.